High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration
- Title
- High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration
- Author
- 김진기
- Keywords
- binary mixture core; controlled release; high payload; itraconazole; lipid nanoparticles; DRUG-DELIVERY; PHARMACOKINETIC PROPERTIES; DISSOLUTION BEHAVIOR; PHYSICAL STABILITY; DIFFUSION METHOD; SLN; CARRIERS; BIOAVAILABILITY; FORMULATION; NLC
- Issue Date
- 2017-09
- Publisher
- WILEY-BLACKWELL
- Citation
- JOURNAL OF PHARMACY AND PHARMACOLOGY, v. 69, No. 8, Page. 955-966
- Abstract
- Objectives : The aim of this study was to develop high payload itraconazole-incorporated lipid nanoparticles (HINP) with modulated release property using a binary mixture core of solid and liquid lipid for oral and parenteral administration.
Methods : High payload itraconazole-incorporated lipid nanoparticles were prepared by hot high-pressure homogenization method using tristearin (TS) as a solid lipid, triolein (TO) as a liquid lipid and egg phosphatidylcholine/Tween 80/DSPE-PEG(2000) as a surfactants mixture. To investigate the effects of liquid lipid in lipid core on itraconazole (ITZ) dissolution and release, TS/TO ratio was varied as 100/0, 90/10 and 80/20 (mg/mg).
Key findings : All HINP formulations showed particle size around 300 nm and polydispersity index below 0.3. The incorporation efficiencies of HINP formulations were above 80%, and more than 40 mg of ITZ was incorporated into each HINP formulation. In-vitro dissolution and release rate of ITZ from HINP increased as the amount of TO in lipid core increased. Compared with commercial formulations of ITZ, the pharmacokinetics of ITZ was improved after oral and parenteral administration of HINP formulations containing 0% or 10% of TO in lipid core.
Conclusion : High payload itraconazole-incorporated lipid nanoparticles with a binary mixture lipid core have a great potential for the development of controlled release formulation of ITZ.
- URI
- https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.12727https://repository.hanyang.ac.kr/handle/20.500.11754/103601
- ISSN
- 0022-3573; 2042-7158
- DOI
- 10.1111/jphp.12727
- Appears in Collections:
- COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML